Skip to main content
Top
Published in: International Urology and Nephrology 1/2015

01-01-2015 | Urology – Original Paper

Urinary TGF-1 has a supplementary value in predicting renal function recovery post unilateral ureteral obstruction

Authors: Xiaoxiang Chen, Wei Zhu, Samih Al-Hayek, Xiang Yan, Chunming Jiang, Xi Zheng, Hongqian Guo

Published in: International Urology and Nephrology | Issue 1/2015

Login to get access

Abstract

Purpose

To evaluate whether urine transforming growth factor-β1 (TGF-β1) can help identifying kidneys that would recover their function after drainage of unilateral ureteric obstructive.

Methods

Forty-five patients with unilateral ureteral obstruction were included. Glomerular filtration rate (GFR) of the obstructed kidney was <10 ml/min, and all patients were treated with percutaneous nephrostomy. TGF-β1 level was measured in the urine from the obstructed kidney at the time of drainage. GFR before nephrostomy insertion and 3 months after were calculated.

Results

Patients with renal function improvement (significant increase in GFR) after nephrostomy insertion had significantly lower concentration of urine TGF-β1 (p < 0.05) compared with the group that showed no change in GFR (non-functioning kidneys) The sensitivity, specificity and accuracy of urine TGF-β1 in identifying non-functioning kidney was 82, 82 and 82 %, respectively.

Conclusions

Urine TGF-β1 is a cytokine leading to renal fibrosis and has a supplementary value in differentiating, at early stage, between kidneys that would recover function after releasing unilateral ureteral obstruction from those which will not (non-functioning kidneys).
Literature
1.
2.
go back to reference El-Sherbiny MT, Mousa OM, Shokeir AA, Ghoneim MA (2002) Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children. J Urol 168:1798–1800PubMedCrossRef El-Sherbiny MT, Mousa OM, Shokeir AA, Ghoneim MA (2002) Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children. J Urol 168:1798–1800PubMedCrossRef
3.
go back to reference Furness PD 3rd, Maizels M, Han SW, Cohn RA, Cheng EY (1999) Elevated bladder urine concentration of transforming growth factor-beta1 correlates with upper urinary tract obstruction in children. J Urol 162:1033–1036PubMedCrossRef Furness PD 3rd, Maizels M, Han SW, Cohn RA, Cheng EY (1999) Elevated bladder urine concentration of transforming growth factor-beta1 correlates with upper urinary tract obstruction in children. J Urol 162:1033–1036PubMedCrossRef
4.
go back to reference Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY (1997) Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction. Urology 50:769–773PubMedCrossRef Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY (1997) Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction. Urology 50:769–773PubMedCrossRef
5.
go back to reference Gulmi FA, Felsen D, Vaughan ED Jr (2002) Pathophysiology of urinary tract obstruction in Campbell’s urology. WB Saunders, Philadelphia Gulmi FA, Felsen D, Vaughan ED Jr (2002) Pathophysiology of urinary tract obstruction in Campbell’s urology. WB Saunders, Philadelphia
6.
go back to reference Bander SJ, Buerkert JE, Martin D, Klahr S (1985) Long-term effects of 24-hr unilateral ureteral obstruction on renal function in the rat. Kidney Int 28:614–620PubMedCrossRef Bander SJ, Buerkert JE, Martin D, Klahr S (1985) Long-term effects of 24-hr unilateral ureteral obstruction on renal function in the rat. Kidney Int 28:614–620PubMedCrossRef
7.
go back to reference Flam T, Venot A, Bariety J (1984) Reversible hydronephrosis in the rat: a new surgical technique assessed by radioisotopic measurements. J Urol 131:796–798PubMed Flam T, Venot A, Bariety J (1984) Reversible hydronephrosis in the rat: a new surgical technique assessed by radioisotopic measurements. J Urol 131:796–798PubMed
8.
go back to reference McDougal WS (1982) Pharmacologic preservation of renal mass and function in obstructive uropathy. J Urol 128:418–421PubMed McDougal WS (1982) Pharmacologic preservation of renal mass and function in obstructive uropathy. J Urol 128:418–421PubMed
9.
go back to reference Vaughan ED Jr, Sweet RE, Gillenwater JY (1973) Unilateral ureteral occlusion: pattern of nephron repair and compensatory response. J Urol 109:979–982PubMed Vaughan ED Jr, Sweet RE, Gillenwater JY (1973) Unilateral ureteral occlusion: pattern of nephron repair and compensatory response. J Urol 109:979–982PubMed
10.
go back to reference Bohle A, Mackensen-Haen S, Wehrmann M (1996) Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 19:191–195PubMedCrossRef Bohle A, Mackensen-Haen S, Wehrmann M (1996) Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 19:191–195PubMedCrossRef
11.
go back to reference Bohle A, Muller G, Wehrmann M, Mackensen-Haen S, Xiao JC (1996) Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl 54:S2–S9PubMed Bohle A, Muller G, Wehrmann M, Mackensen-Haen S, Xiao JC (1996) Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl 54:S2–S9PubMed
12.
go back to reference Schainuck LI, Striker GE, Cutler RE, Benditt EP (1970) Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1:631–641PubMedCrossRef Schainuck LI, Striker GE, Cutler RE, Benditt EP (1970) Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1:631–641PubMedCrossRef
14.
go back to reference Rahn KH, Heidenreich S, Bruckner D (1999) How to assess glomerular function and damage in humans. J Hypertens 17:309–317PubMedCrossRef Rahn KH, Heidenreich S, Bruckner D (1999) How to assess glomerular function and damage in humans. J Hypertens 17:309–317PubMedCrossRef
15.
go back to reference Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483PubMedCrossRef Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483PubMedCrossRef
16.
go back to reference Stevens LA, Levey AS (2009) Measured GFR as a confirmatory test for estimated GFR. JASN 20:2305–2313PubMedCrossRef Stevens LA, Levey AS (2009) Measured GFR as a confirmatory test for estimated GFR. JASN 20:2305–2313PubMedCrossRef
17.
go back to reference Ozulker F, Ozulker T, Uzun AK (2011) Investigation of the efficacy of 99 mTc-DTPA scintigraphic GFR measurement with Gates method in the detection of cisplatin-induced nephrotoxicity in comparison with plasma. Med Oncol 28:1101–1106PubMedCrossRef Ozulker F, Ozulker T, Uzun AK (2011) Investigation of the efficacy of 99 mTc-DTPA scintigraphic GFR measurement with Gates method in the detection of cisplatin-induced nephrotoxicity in comparison with plasma. Med Oncol 28:1101–1106PubMedCrossRef
18.
go back to reference Katz R, Pode D, Golijanin D, Gofrit ON, Shenfeld OZ, Shapiro A, Reissman P (2004) Laparoscopic nephrectomy for infected, obstructed and non-functioning kidneys. Surg Laparosc Endosc Percutan Tech 14:340–343PubMedCrossRef Katz R, Pode D, Golijanin D, Gofrit ON, Shenfeld OZ, Shapiro A, Reissman P (2004) Laparoscopic nephrectomy for infected, obstructed and non-functioning kidneys. Surg Laparosc Endosc Percutan Tech 14:340–343PubMedCrossRef
19.
go back to reference Tepeler A, Akman T, Tok A, Kaba M, Binbay M, Müslümanoğlu AY, Tefekli A (2012) Retroperitoneoscopic nephrectomy for non-functioning kidneys related to renal stone disease. Urol Res 40:559–565PubMedCrossRef Tepeler A, Akman T, Tok A, Kaba M, Binbay M, Müslümanoğlu AY, Tefekli A (2012) Retroperitoneoscopic nephrectomy for non-functioning kidneys related to renal stone disease. Urol Res 40:559–565PubMedCrossRef
20.
go back to reference De Muro P, Faedda R, Frescu P, Masala A, Cigni A, Concas G, Mela MG, Satta A, Carcassi A, Sanna GM, Cherchi GM (2004) Urinary transforming growth factor-beta 1 in various types of nephropathy. Pharmacol Res 49:293–298PubMedCrossRef De Muro P, Faedda R, Frescu P, Masala A, Cigni A, Concas G, Mela MG, Satta A, Carcassi A, Sanna GM, Cherchi GM (2004) Urinary transforming growth factor-beta 1 in various types of nephropathy. Pharmacol Res 49:293–298PubMedCrossRef
21.
go back to reference Yang Y, Hou Y, Wang CL, Ji SJ (2006) Renal expression of epidermal growth factor and transforming growth factor-beta1 in children with congenital hydronephrosis. Urology 67:817–821PubMedCrossRef Yang Y, Hou Y, Wang CL, Ji SJ (2006) Renal expression of epidermal growth factor and transforming growth factor-beta1 in children with congenital hydronephrosis. Urology 67:817–821PubMedCrossRef
22.
go back to reference Border WA, Noble NA (1997) TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 51:1388–1396PubMedCrossRef Border WA, Noble NA (1997) TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 51:1388–1396PubMedCrossRef
23.
go back to reference Border WA, Noble NA (1998) Interactions of transforming growth factor β and angiotensin II in renal fibrosis. Hypertension 31:181–188PubMedCrossRef Border WA, Noble NA (1998) Interactions of transforming growth factor β and angiotensin II in renal fibrosis. Hypertension 31:181–188PubMedCrossRef
24.
go back to reference Murakami K, Takamura T, Hino S, Yoshioka K (1997) Urinary transforming growth factor-beta in patients with glomerular diseases. Pediatr Nephrol 11:334–336PubMedCrossRef Murakami K, Takamura T, Hino S, Yoshioka K (1997) Urinary transforming growth factor-beta in patients with glomerular diseases. Pediatr Nephrol 11:334–336PubMedCrossRef
25.
26.
go back to reference El-Sherbiny MT, Mousa OM, Shokeir AA, Ghoneim MA (2002) Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children. J Urol 168:1798–1800PubMedCrossRef El-Sherbiny MT, Mousa OM, Shokeir AA, Ghoneim MA (2002) Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children. J Urol 168:1798–1800PubMedCrossRef
Metadata
Title
Urinary TGF-1 has a supplementary value in predicting renal function recovery post unilateral ureteral obstruction
Authors
Xiaoxiang Chen
Wei Zhu
Samih Al-Hayek
Xiang Yan
Chunming Jiang
Xi Zheng
Hongqian Guo
Publication date
01-01-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0846-3

Other articles of this Issue 1/2015

International Urology and Nephrology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.